Literature DB >> 33822550

[Morphological characteristics of pulmonary tuberculosis concurrent with lung cancer].

T A Novitskaya1,2, B M Ariel1, I V Dvorakovskaya1,3, A O Avetisyan1, P K Yablonsky1,2.   

Abstract

The pathogenetic relationship between pulmonary tuberculosis and lung cancer in their concurrence is now still the subject of discussion.
OBJECTIVE: To study the pathogenetic relationship between pulmonary tuberculosis and lung cancer.
MATERIAL AND METHODS: The investigators examined surgical material from 51 patients (41 men) aged 41-73 years (mean age, 63.7 years) with pulmonary tuberculosis concurrent with lung cancer. They also studied tumors, tuberculous caverns, infiltrates, and foci with surrounding macroscopically intact lung tissue, as well as fibrotic changes by histological, histochemical and immunohistochemical examinations.
RESULTS: Previous tuberculosis can be considered as a risk factor for lung cancer. Central cancer was more common in patients with inactive, chronic tuberculosis with a predominance of fibrotic processes in the root of the lung and in its hilar zones. Fibrous-cavernous tuberculosis and cavernous tuberculosis were more frequently concurrent with central cancer; peripheral tumors mainly occurred in infiltrative tuberculosis and tuberculomas.
CONCLUSION: The findings suggest that in a number of cases, cancer and tuberculosis may be anatomically close, developing in the same anatomical unit - the lung. However, this does not indicate an unambiguous etiopathogenetic relationship between pulmonary tuberculosis and lung cancer. The relationships between pulmonary tuberculosis and lung cancer are much more complex and do not fit into the simple scheme of cause-and-effect relations.

Entities:  

Keywords:  cancer; lung; pathogenesis; tuberculosis

Mesh:

Year:  2021        PMID: 33822550     DOI: 10.17116/patol20218302119

Source DB:  PubMed          Journal:  Arkh Patol        ISSN: 0004-1955


  1 in total

Review 1.  The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future.

Authors:  Yongwei Qin; Yujie Chen; Jinliang Chen; Kuang Xu; Feifan Xu; Jiahai Shi
Journal:  Infect Agent Cancer       Date:  2022-05-07       Impact factor: 3.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.